Key players in Allergy Immunotherapy
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | ALK-Abello | — | 33 reports |
| 2 | Stallergenes Greer | — | 33 reports |
| 3 | HAL Allergy | — | 33 reports |
| 4 | Allergy Therapeutics | — | 33 reports |
| 5 | Aimmune (Nestle) | — | 33 reports |
Also active in Allergy Immunotherapy
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Viatris |
|
| Kaleo Inc | |
| Impax Laboratories Inc | |
 Teva Pharmaceutical |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Allergy Immunotherapy reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Allergy Immunotherapy report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.